Metabolic and histological features of non‐alcoholic fatty liver disease patients with different serum alanine aminotransferase levels
Open Access
- 8 January 2009
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 29 (4), 387-396
- https://doi.org/10.1111/j.1365-2036.2008.03896.x
Abstract
Background Non‐alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in affluent countries. Serum alanine aminotransferase (ALT) level is commonly performed to monitor NAFLD patients, but its clinical relevance is unclear. Aim To evaluate the metabolic and histological features of NAFLD patients with different ALT levels. Methods A total of 173 consecutive patients with biopsy‐proven NAFLD were studied. Patients with persistently normal ALT and those with abnormal ALT were compared. Results Patients with persistently normal ALT had lower steatosis grade than patients with abnormal ALT, but they had similar degree of lobular inflammation, ballooning and fibrosis. Among 19 patients with ALT below 0.5 times the upper limit of normal (ULN) at the time of liver biopsies, 8 (42%) and 3 (16%) had steatohepatitis and significant fibrosis respectively. The within‐patient coefficient of variance was similarly high in patients with simple steatosis and steatohepatitis (33.5). Age and glucose, but not ALT, were independent factors associated with significant fibrosis. Discussion Metabolic factors, but not ALT, are associated with histological severity. Patients with ALT < 0.5 × ULN may still have non‐alcoholic steatohepatitis (NASH) and significant fibrosis. Evaluation of NAFLD patients should be based on metabolic risk factors, but not ALT level.Keywords
This publication has 37 references indexed in Scilit:
- Genetic polymorphisms of adiponectin and tumor necrosis factor‐alpha and nonalcoholic fatty liver disease in Chinese peopleJournal of Gastroenterology and Hepatology, 2008
- Serum aminotransferase activity and mortality risk in a United States communityHepatology, 2008
- How should we manage patients with non-alcoholic fatty liver disease in 2007?Journal of Gastroenterology and Hepatology, 2007
- The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLDHepatology, 2007
- Metabolic and Adipokine Profile of Chinese Patients With Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2006
- Nonalcoholic Fatty Liver Disease: From Steatosis to CirrhosisHepatology, 2006
- Prevalence of and risk factors for fatty liver in a general population of Shanghai, ChinaJournal of Hepatology, 2005
- Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseHepatology, 2005
- The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsiesJournal of Hepatology, 2005
- Natural history of nonalcoholic steathepatitis: A longitudinal study of repeat liver biopsiesHepatology, 2004